CAMBRIDGE, Massachusetts (Reuters) – Production of H1N1 swine flu vaccine at two US facilities is "working optimally" with output on the rise, the chief executive of Sanofi-Aventis said on Tuesday. The French pharmaceutical giant had …
Read Original Story: us H1N1 vaccine output rising quickly: Sanofi CEO – Reuters
Who’s at fault for the slow-to-market H1N1 vaccine? USA Today asked consumers, and more than half of them blamed drug companies. Some 62 percent said they blame pharma either a great deal or moderately. The government, by contrast, got 58 percent of …
Read Original Story: US blames drugmakers for slow flu shots – FiercePharma
Amid swirling fear and finger-pointing, Sanofi Pasteur on Wednesday released its latest clinical trials showing that its H1N1 vaccine is safe and said it can deliver the 75 million doses as promised by the end …
Read Original Story: Sanofi Pasteur says H1N1 vaccine is safe – Allentown Morning Call
CAMBRIDGE, Mass., Nov 10 (Reuters) – Production of H1N1 swine flu vaccine at two facilities in Pennsylvania is "working optimally," with output on the rise, the chief executive of Sanofi-Aventis SA (SASY.PA) said on Tuesday. …
Read Original Story: Sanofi CEO-US H1N1 vaccine output rising quickly – Reuters
Sanofi-Aventis Group, under pressure with other vaccine makers to meet intense public demand for flu vaccine in the United States, on Wednesday said it solved problems that had slowed production and is working around the clock to deliver the 75 million …
Read Original Story: Work on flu vaccine ratchets up – Minneapolis Star Tribune
Swiftwater, Pennsylvania (CNN) — Vaccine manufacturing giant Sanofi Pasteur opened its doors to the media Wednesday, inviting reporters to a first-of-its-kind, up-close look at its H1N1flu vaccine production facility. …
Read Original Story: H1N1 vaccine maker Sanofi Pasteur gives tour to journalists – CNN
The vaccines unit of French pharmaceutical company Sanofi-Aventis SA (SNY, SAN.FR) confirmed the initial analysis of its H1N1 vaccine in both adults and children. The company had said the product produced a "robust" immune response on adult test …
Read Original Story: Sanofi Confirms Safety, Effectiveness of Its H1N1 Vaccine – Wall Street Journal
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an impressive show of force by the …
Read Original Story: Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston … – Xconomy
(NBC) – There’s progress to report in getting more swine flu vaccine out to the public. The FDA has ok’d another version of the vaccine and that company promises to get out more than seven million doses by the end of next month. …
Read Original Story: H1N1 vaccine supply boost – 14WFIE.com
Chris Viehbacher, the CEO of Sanofi-Aventis, told the Health Blog a while back that he planned to shift a big chunk of research funding away from Sanofi’s internal labs and toward external partnerships with smaller, …
Read Original Story: Sanofi's Research Shift: Billion-Dollar Deal, Venture Capital Fund – Wall Street Journal (blog)
